A Phase I Study to Investigate the Absorption, Metabolism, and Excretion of KD101 in Male Subjects
Phase of Trial: Phase I
Latest Information Update: 02 May 2017
At a glance
- Drugs KD 101 (Primary)
- Indications Obesity
- Focus Pharmacokinetics
- 26 Apr 2017 Planned End Date changed from 1 Jan 2017 to 1 Jul 2017.
- 05 Sep 2016 Status changed from not yet recruiting to recruiting.
- 12 Jul 2016 New trial record